Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability
Journal of Thrombosis and Haemostasis · 2024
DOI: 10.1016/j.jtha.2023.10.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Aisling M Rehill und 13 weiteren Autor:innen. Beteiligte Einrichtung: Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland University of Medicine and Heal…. Hauptthemen laut MEDLINE: Protein C, Thrombophilia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland, Health Research Board, National Children's Research Centre.
Abstract (Originalsprache)
BACKGROUND: Myeloid cell metabolic reprogramming is a hallmark of inflammatory disease; however, its role in inflammation-induced hypercoagulability is poorly understood. OBJECTIVES: We aimed to evaluate the role of inflammation-associated metabolic reprogramming in regulating blood coagulation. METHODS: We used novel myeloid cell-based global hemostasis assays and murine models of immunometabolic disease. RESULTS: Glycolysis was essential for enhanced activated myeloid cell tissue factor expression and decryption, driving increased cell-dependent thrombin generation in response to inflammatory challenge. Similarly, inhibition of glycolysis enhanced activated macrophage fibrinolytic activity through reduced plasminogen activator inhibitor 1 activity. Macrophage polarization or activation markedly increased endothelial protein C receptor (EPCR) expression on monocytes and macrophages, leading to increased myeloid cell-dependent protein C activation. Importantly, inflammation-dependent EPCR expression on tissue-resident macrophages was also observed in vivo. Adipose tissue macrophages from obese mice fed a high-fat diet exhibited significantly enhanced EPCR expression and activated protein C generation compared with macrophages isolated from the adipose tissue of healthy mice. Similarly, the induction of colitis in mice prompted infiltration of EPCR+ innate myeloid cells within inflamed colonic tissue that were absent from the intestinal tissue of healthy mice. CONCLUSION: Collectively, this study identifies immunometabolic regulation of myeloid cell hypercoagulability, opening new therapeutic possibilities for targeted mitigation of thromboinflammatory disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland; National Children's Research Centre, Chi…
- Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland.
- National Children's Research Centre, Children's Health Ireland Crumlin, Dublin, Ireland; Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Ireland.
- Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland; Institute of Clinical Chemistry and Labo…
- National Children's Research Centre, Children's Health Ireland Crumlin, Dublin, Ireland; Department of Paediatrics, University College Dublin and Royal College of Surgeons in Ireland University of Medicine and Health Sc…
Förderung
- Science Foundation Ireland
- Health Research Board
- National Children's Research Centre
Zitieren
APA
Rehill, A. M., Leon, G., McCluskey, S., Schoen, I., Hernandez-Santana, Y., Annett, S., Klavina, P., Robson, T., Curtis, A. M., Renné, T., Hussey, S., O'Donnell, J. S., Walsh, P. T., & Preston, R. J. S. (2024). Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.10.006
Vancouver
Rehill AM, Leon G, McCluskey S, Schoen I, Hernandez-Santana Y, Annett S, et al. Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2023.10.006
BibTeX
@article{Rehill2024,
author = {Rehill, Aisling M and Leon, Gemma and McCluskey, Sean and Schoen, Ingmar and Hernandez-Santana, Yasmina and Annett, Stephanie and Klavina, Paula and Robson, Tracy and Curtis, Annie M and Renné, Thomas and Hussey, Seamus and O'Donnell, James S and Walsh, Patrick T and Preston, Roger J S},
title = {Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
doi = {10.1016/j.jtha.2023.10.006}
}
EUVIMED